tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
Holding CTNM?
Track your performance easily

Contineum Therapeutics, Inc. Class A (CTNM) Cash flow

167 Followers

Contineum Therapeutics, Inc. Class A Cash Flow

CTNM's free cash flow for Q3 2024 was $-6.23M. For the 2024 fiscal year, CTNM's free cash flow was decreased by $39.17M and operating cash flow was $-6.17M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22
Operating Cash Flow
$ -25.37M$ 19.35M$ -20.12M
Investing Cash Flow
$ -60.05M$ -65.57M$ 22.30M
Financing Cash Flow
$ 108.06M$ 56.18M$ -1.24M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
$ 118.12M$ 15.53M$ 5.57M
Income Tax Paid Supplemental Data
$ 450.00K$ 450.00K-
Interest Paid Supplemental Data
-$ 150.00K$ 225.00K
Issuance Of Capital Stock
$ 108.21M--
Issuance Of Debt
-$ -3.75M$ -1.25M
Repayment Of Debt
-$ -3.75M$ -1.25M
Free Cash Flow
$ -25.86M$ 18.93M$ -20.24M
Domestic Sales
---
Foreign Sales
---
Currency in USD

Contineum Therapeutics, Inc. Class A Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis